Ellen successfully completed her Honours research with the Ruitenberg Lab in 2017, and then returned to the lab in 2018 to begin her PhD. Her work focusses on investigating the mechanism of action of a therapeutic called IVIG (intravenous immunoglobulin), and she is specifically aiming to understand how IVIG works to improve recovery from acute spinal cord injury.